We got a number of important drugs from the Celgene acquisition, says Bristol Myers Squibb CEO

Bristol Myers Squibb

FDA approves new Bristol Myers Squibb schizophrenia drug

Bloomsbury Publishing (BMY) Share Price

BMY Stock Breaks Out As FDA OKs Schizophrenia Drug

ADVFN

Why Pharma Giant Bristol-Myers Squibb’s Shares Took a Big Hit Today

Bristol Myers Squibb stock rises, Merck moves lower. Here's why.

This Biotech Has Surged 416%. Now, There's A Game Changer.